Top Markets
#1 Islamic Coin Islamic Coin +154.27%
#2 PulseChain PulseChain +52.83%
#3 BOOK OF MEME BOOK OF MEME +44.89%
#4 DogBull DogBull +34.92%
#5 Nockchain Nockchain +18.68%
#6 ORDI ORDI +17.36%
#7 Ergo Ergo +17.32%
#8 rsERG rsERG +16.99%
#9 Bio Protocol Bio Protocol +16.75%
#10 PondCoin PondCoin +16.22%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
주식 순위 #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
주가
$2.18
마지막 동기화: 2026-08-19
시가총액
$35.55M
변동 (1일)
2.57%
변동 (1년)
-33.19%
국가
US
거래 Grace Therapeutics, Inc. (GRCE)

카테고리

Healthcare
Grace Therapeutics, Inc. (GRCE)의 주가 이력
최고 종가: $2.13 (2026-08-01 기준)

최저 종가: $3.24 (2024-10-01 기준)
Grace Therapeutics, Inc.의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $758.23 6.53%
CH